Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function. (Q38104708)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Genny Del Zotto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Mariella Della Chiesa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Maria Cristina Mingari

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Alessandro Moretta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Andrea De Maria

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Lorenzo Moretta

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

1 reference

6 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

702-713

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recogn

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Killer immunoglobulin-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

MHC class I molecules and KIRs in human history, health and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

p46, a novel natural killer cell-specific surface molecule that mediates cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

NK cells and their receptors during viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNα production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Natural killer-cell differentiation by myeloid progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Human natural killer cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

NK cells can generate from precursors in the adult human liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Innate lymphoid cells--a proposal for uniform nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Imprint of human cytomegalovirus infection on the NK cell receptor repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Human NK cells can control CMV infection in the absence of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Persistence of natural killer cells with expansion of a hypofunctional CD56-CD16+KIR+NKG2C+ subset in a patient with atypical Janus kinase 3-deficient severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Activation of natural killer cells during acute infection with hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Umbilical cord blood T cells express multiple natural cytotoxicity receptors after IL-15 stimulation, but only NKp30 is functional

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

TOX regulates the differentiation of human natural killer cells from hematopoietic stem cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

A novel myeloid-like NK cell progenitor in human umbilical cord blood

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Plasticity of NK-cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Cytotoxic functions and susceptibility to apoptosis of human CD56(bright) NK cells differentiated in vitro from CD34⁺ hematopoietic progenitors

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Identification of a NCR+/NKG2D+/LFA-1(low)/CD94(-) immature human NK cell subset

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

CD27 defines phenotypically and functionally different human NK cell subsets.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Impaired activating receptor expression pattern in natural killer cells from patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.22302

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.22302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23650273%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference